Overview

Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease

Status:
Not yet recruiting
Trial end date:
2027-05-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare/harmonize cross-sectional and longitudinal tau tangle measurements obtained with the tau PET radiopharmaceuticals Flortaucipir and MK-6240 to elucidate the advantages and caveats of their use in clinical trials/practice and provide parameters to integrate their estimates.
Phase:
Phase 1
Details
Lead Sponsor:
Tharick Pascoal
Collaborator:
National Institute on Aging (NIA)
Treatments:
Radiopharmaceuticals